Adventist Health System-Sunbelt, INC

Adventist Health System-Sunbelt, INC was paid $173.98M by Medicaid between Jan 2018 and Dec 2024, across 831 billing codes. Its largest line is 99283, emergency room visit (moderate) — 12% of everything it billed.

33Billing provider infoADVENTIST HEALTH SYSTEM-SUNBELT, INC
ORLANDO, FL 32803

33aNPI1306938071assigned 09/29/2006

33bProvider typeLand Ambulance

28Total paid$173.98M

24GClaims7,596,642

24DCodes billed831

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Land Ambulance providers in Florida

Rank by total paid#1 of 87

Median peer was paid$558K

This provider vs. median312×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	623,675	$10.75M
2019	1,532,859	$33.83M
2020	1,465,846	$30.82M
2021	1,804,559	$41.98M
2022	1,783,358	$39.40M
2023	343,238	$13.91M
2024incomplete	43,107	$3.30M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	12%	321,046	239,780	$20.78M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.1%	257,029	186,838	$15.80M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.9%	133,722	93,721	$8.60M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	4.8%	69,144	17,523	$8.32M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.9%	97,984	27,675	$5.02M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.9%	39,952	29,584	$5.00M
90935	Hemodialysis procedure with single evaluation by a physician	2.8%	27,376	3,315	$4.83M
80053	Comprehensive metabolic panel	2.5%	293,891	195,889	$4.28M
96367		2.2%	13,266	7,730	$3.79M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.0%	59,414	44,629	$3.51M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.7%	53,172	35,156	$2.98M
96361	Intravenous infusion, hydration; each additional hour	1.7%	63,179	45,620	$2.94M

819 more codes

84703		1.7%	151,325	$2.92M
G0378	Hospital observation service, per hour	1.6%	118,397	$2.83M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.5%	63,893	$2.61M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.3%	58,028	$2.30M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.2%	54,385	$2.17M
70450	Computed tomography, head or brain; without contrast material	1.2%	40,311	$2.14M
96375	Therapeutic injection; each additional sequential IV push	1.1%	135,597	$1.87M
J9271	Injection, pembrolizumab, 1 mg	1.1%	1,317	$1.85M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	17,609	$1.56M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	21,126	$1.52M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	151,513	$1.36M
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	29,777	$1.34M
77386		<1%	6,960	$1.30M
71275	Computed tomographic angiography, chest, with contrast material	<1%	11,706	$1.21M
97161		<1%	15,103	$1.18M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	24,335	$1.17M
80048	Basic metabolic panel (calcium, ionized)	<1%	140,748	$1.15M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	15,317	$1.10M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	33,213	$1.07M
86900		<1%	32,617	$1.05M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	87,007	$1.05M
77412		<1%	7,006	$970K
44970		<1%	1,045	$960K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	11,591	$932K
82947		<1%	121,149	$923K
90999	Dialysis (unlisted procedure)	<1%	4,096	$851K
59025	Fetal non-stress test	<1%	27,198	$851K
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	5,927	$795K
84484		<1%	119,005	$754K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	27,795	$738K
01999		<1%	17,815	$723K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,060	$718K
A0431	Ambulance service, conventional air services, transport, one way (rotary wing)	<1%	782	$692K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	5,979	$680K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	59,707	$668K
84702		<1%	30,742	$623K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	6,047	$607K
47562		<1%	994	$577K
92523		<1%	4,661	$563K
81003		<1%	220,069	$546K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	11,898	$536K
41899	Unlisted procedure, dentoalveolar structures	<1%	2,933	$512K
J2505	Injection, pegfilgrastim, 6 mg	<1%	1,149	$506K
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	6,566	$503K
A0427	Emergency ambulance ride, advanced life support	<1%	4,542	$501K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	1,429	$493K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	373,912	$479K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	26,505	$473K
J9035	Injection, bevacizumab, 10 mg	<1%	1,523	$460K
J1644	Injection, heparin sodium, per 1000 units	<1%	33,435	$454K
92526		<1%	11,900	$447K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	17,051	$433K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	5,194	$421K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	20,561	$417K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	19,115	$407K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	24,202	$394K
75574		<1%	4,503	$392K
71046	Radiologic examination, chest; 2 views	<1%	34,335	$388K
58661		<1%	496	$382K
85027		<1%	61,327	$379K
J1756	Injection, iron sucrose, 1 mg	<1%	7,487	$365K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,840	$358K
87088		<1%	82,543	$356K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	17,485	$355K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	5,895	$340K
84443	Thyroid stimulating hormone (TSH)	<1%	46,812	$339K
99213	Doctor's office visit, returning patient (routine)	<1%	8,176	$336K
96415		<1%	3,888	$327K
54161		<1%	729	$314K
96376		<1%	51,622	$314K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	5,674	$314K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	784	$312K
49083		<1%	3,600	$300K
83880		<1%	29,658	$290K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	21,452	$280K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	159,608	$279K
71045	Radiologic examination, chest; single view	<1%	109,978	$279K
95811		<1%	826	$274K
97165		<1%	3,922	$269K
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,174	$265K
36415	Collection of venous blood by venipuncture	<1%	77,864	$264K
95813		<1%	957	$258K
84520		<1%	7,702	$252K
85610		<1%	73,135	$250K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,332	$243K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	9,564	$242K
10060		<1%	3,811	$239K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	16,640	$239K
97116		<1%	17,190	$238K
J2501	Injection, paricalcitol, 1 mcg	<1%	11,744	$233K
97164		<1%	2,964	$232K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	25,628	$228K
D7140	Extraction, erupted tooth or exposed root	<1%	958	$227K
80047		<1%	9,228	$226K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	10,675	$218K
70491		<1%	2,286	$218K
73610		<1%	11,631	$216K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	60,725	$214K
36561		<1%	564	$212K
83970		<1%	5,758	$208K
72125	Computed tomography, cervical spine; without contrast material	<1%	8,650	$208K
J3490	Unclassified drugs	<1%	4,529	$204K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,351	$196K
70498		<1%	1,467	$195K
97162		<1%	6,367	$193K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	527	$191K
J7030	Infusion, normal saline solution , 1000 cc	<1%	159,596	$190K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,911	$189K
A9270	Non-covered item or service	<1%	22,599	$184K
76819	Fetal biophysical profile; without non-stress testing	<1%	6,546	$182K
J0690	Injection, cefazolin sodium, 500 mg	<1%	19,268	$173K
77334		<1%	2,027	$169K
76830	Ultrasound, transvaginal	<1%	13,766	$169K
86850		<1%	18,743	$168K
97168		<1%	1,619	$168K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	18,027	$161K
92587		<1%	3,971	$161K
58571		<1%	118	$160K
C1769	Guide wire	<1%	7,645	$159K
92610		<1%	2,643	$159K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,287	$155K
73130		<1%	9,434	$152K
88185		<1%	2,739	$152K
36430		<1%	5,005	$151K
93971		<1%	9,103	$151K
73630		<1%	13,099	$145K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	41,238	$145K
80076		<1%	22,909	$143K
97535	Self-care/home management training, each 15 minutes	<1%	6,859	$141K
76801		<1%	19,264	$140K
97150	Therapeutic procedure(s), group (2 or more individuals)	<1%	11,246	$137K
97602		<1%	2,595	$133K
92588		<1%	1,171	$133K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	41,379	$133K
84100		<1%	16,555	$133K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	2,673	$132K
A0434	Specialty care transport (sct)	<1%	755	$131K
76770		<1%	4,533	$130K
Q5105	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units	<1%	6,050	$129K
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	692	$128K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	968	$124K
73564		<1%	11,083	$123K
J0897	Injection, denosumab, 1 mg	<1%	1,088	$123K
82803		<1%	7,166	$122K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	13,659	$121K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	23,118	$120K
82728		<1%	11,696	$119K
86923		<1%	3,213	$117K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	4,584	$117K
J0485	Injection, belatacept, 1 mg	<1%	1,048	$117K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	534	$115K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	741	$114K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	253	$113K
84132		<1%	8,260	$110K
77336		<1%	4,368	$109K
83550		<1%	7,875	$108K
36591		<1%	3,504	$106K
70496		<1%	1,879	$105K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	3,606	$105K
77295		<1%	375	$105K
83540		<1%	10,325	$103K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	118,914	$102K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	4,029	$101K
82657		<1%	1,095	$101K
87210		<1%	37,743	$100K
97113		<1%	2,280	$98K
A0436	Rotary wing air mileage, per statute mile	<1%	748	$97K
93458		<1%	424	$96K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	3,037	$95K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	6,012	$95K
73140		<1%	4,092	$95K
74018		<1%	7,744	$95K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	3,998	$90K
77290		<1%	658	$89K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,378	$89K
99203	Doctor's office visit, new patient (routine)	<1%	2,372	$88K
J7050	Infusion, normal saline solution, 250 cc	<1%	40,520	$88K
76536		<1%	2,084	$87K
73030		<1%	9,367	$86K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	1,065	$85K
70310		<1%	1,798	$85K
82274		<1%	4,232	$82K
82565		<1%	15,396	$81K
84436		<1%	1,783	$80K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	393	$79K
97597		<1%	1,957	$79K
97166		<1%	1,471	$77K
85014		<1%	15,343	$76K
52356		<1%	104	$76K
93970		<1%	4,621	$76K
73110		<1%	6,926	$74K
89060		<1%	2,202	$74K
J2704	Injection, propofol, 10 mg	<1%	31,100	$74K
82731		<1%	1,027	$74K
96402		<1%	1,441	$73K
77066	Tomosynthesis, mammo	<1%	1,894	$73K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	33,117	$73K
93976		<1%	4,155	$72K
J1442	Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram	<1%	1,814	$72K
93017		<1%	2,757	$71K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29,300	$71K
78306		<1%	1,028	$70K
80197		<1%	6,718	$70K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	1,275	$69K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,859	$69K
73080		<1%	4,711	$68K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	12,473	$68K
70486		<1%	3,288	$66K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	295	$66K
83735		<1%	58,822	$66K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	22,969	$66K
71250		<1%	3,762	$65K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	59,756	$65K
J9395	Injection, fulvestrant, 25 mg	<1%	351	$65K
80061	Lipid panel	<1%	30,949	$65K
12001		<1%	4,054	$64K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	5,086	$64K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,499	$62K
J9299	Injection, nivolumab, 1 mg	<1%	67	$60K
85018		<1%	8,264	$59K
96416		<1%	1,205	$59K
86901		<1%	32,489	$59K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	39,860	$58K
86833		<1%	1,062	$57K
J9312	Injection, rituximab, 10 mg	<1%	211	$56K
C1788	Port, indwelling (implantable)	<1%	602	$55K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	40,576	$55K
84156		<1%	7,705	$55K
J2997	Injection, alteplase recombinant, 1 mg	<1%	852	$55K
29125		<1%	2,471	$55K
74230		<1%	686	$54K
12011		<1%	3,816	$53K
72131		<1%	2,694	$52K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,754	$52K
87497		<1%	2,683	$51K
89050		<1%	2,132	$51K
74183		<1%	1,411	$51K
87070		<1%	8,475	$51K
76642		<1%	2,393	$51K
93308		<1%	1,040	$50K
80074		<1%	1,813	$50K
96368		<1%	2,360	$49K
86832		<1%	1,112	$49K
72100		<1%	7,390	$49K
82247		<1%	2,599	$48K
88307		<1%	3,996	$48K
84112		<1%	405	$48K
96523		<1%	4,109	$46K
88304		<1%	4,181	$46K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,984	$45K
0100U		<1%	1,426	$45K
97014		<1%	11,889	$44K
76870		<1%	2,721	$42K
73502		<1%	4,864	$41K
96377		<1%	509	$41K
83690		<1%	79,181	$41K
74021		<1%	2,565	$39K
J1170	Injection, hydromorphone, up to 4 mg	<1%	23,068	$39K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,120	$39K
78264		<1%	337	$38K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	26,906	$38K
83036	Hemoglobin; glycosylated (A1C)	<1%	29,962	$38K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,854	$37K
77300		<1%	1,333	$36K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,888	$36K
93505		<1%	116	$35K
72197		<1%	558	$35K
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,164	$34K
73090		<1%	5,781	$34K
73100		<1%	1,900	$33K
52332		<1%	231	$33K
84460		<1%	1,683	$33K
92950		<1%	632	$33K
95716		<1%	835	$33K
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,237	$33K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,167	$32K
95816		<1%	948	$32K
84439		<1%	18,453	$32K
J3370	Injection, vancomycin hcl, 500 mg	<1%	3,952	$32K
92650		<1%	1,079	$32K
73590		<1%	5,484	$31K
73660		<1%	1,487	$31K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	921	$30K
87340		<1%	4,250	$30K
85730		<1%	33,447	$30K
84145		<1%	4,649	$30K
72141		<1%	1,096	$30K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,911	$30K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	4,409	$30K
87186		<1%	23,789	$29K
80177		<1%	3,354	$29K
72040		<1%	4,262	$29K
86304		<1%	778	$29K
76010		<1%	578	$29K
77280		<1%	222	$29K
86706		<1%	2,435	$29K
70544		<1%	2,137	$28K
74240		<1%	542	$28K
69200		<1%	400	$28K
12002		<1%	2,069	$27K
82040		<1%	226	$27K
84450		<1%	758	$27K
50590		<1%	66	$26K
73070		<1%	1,626	$26K
96401		<1%	1,666	$26K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	404	$25K
73700		<1%	1,292	$25K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	321	$24K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	100	$24K
85097		<1%	538	$24K
76641		<1%	668	$24K
87653		<1%	1,673	$23K
73552		<1%	2,194	$23K
82607		<1%	11,569	$23K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	72	$23K
87040		<1%	11,543	$22K
77080		<1%	999	$22K
97163		<1%	799	$22K
87205		<1%	7,644	$22K
83605		<1%	13,737	$22K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	36	$22K
74022		<1%	4,697	$22K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	368	$22K
99152		<1%	3,344	$21K
J7070	Infusion, d5w, 1000 cc	<1%	30,204	$21K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	96,368	$21K
69209		<1%	316	$21K
36592		<1%	867	$20K
J9310	Injection, rituximab, 100 mg	<1%	49	$20K
86140		<1%	21,519	$20K
71101		<1%	2,594	$20K
87799		<1%	2,418	$20K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	13,118	$20K
29515		<1%	1,161	$20K
92508	Group treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	894	$20K
87506		<1%	1,392	$19K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	32	$19K
82784		<1%	3,265	$19K
82310		<1%	143	$19K
84295		<1%	2,041	$19K
86922		<1%	1,513	$19K
96409		<1%	1,050	$19K
77301		<1%	49	$19K
C1781	Mesh (implantable)	<1%	607	$19K
29105		<1%	626	$18K
A0425	Ground mileage, per statute mile	<1%	17,297	$18K
C1758	Catheter, ureteral	<1%	1,698	$18K
87420		<1%	3,391	$18K
73562		<1%	2,519	$18K
82746		<1%	6,243	$18K
82533		<1%	1,369	$18K
D2330		<1%	209	$18K
88341		<1%	1,789	$18K
70360		<1%	1,181	$17K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	555	$17K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,045	$17K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	109	$17K
38222		<1%	166	$17K
54304		<1%	14	$17K
84481		<1%	2,655	$16K
82330		<1%	1,832	$16K
76937		<1%	1,407	$16K
96417		<1%	4,503	$15K
77072		<1%	589	$15K
J9267	Injection, paclitaxel, 1 mg	<1%	1,192	$15K
82010		<1%	4,841	$15K
43235		<1%	77	$14K
94010		<1%	275	$14K
85379		<1%	21,129	$14K
84075		<1%	68	$14K
84155		<1%	44	$14K
99153	Mod sedat endo service >5yrs	<1%	2,262	$14K
76775		<1%	724	$14K
24640		<1%	154	$14K
70487		<1%	112	$13K
80143		<1%	6,996	$13K
86828		<1%	689	$13K
77065	Tomosynthesis, mammo	<1%	611	$13K
J2060	Injection, lorazepam, 2 mg	<1%	18,280	$13K
87077		<1%	22,850	$13K
72156		<1%	272	$13K
94660		<1%	641	$12K
72158		<1%	424	$12K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	12,021	$12K
73560		<1%	884	$12K
94761		<1%	2,095	$12K
88173		<1%	283	$12K
74178		<1%	170	$11K
73060		<1%	2,114	$11K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	1,298	$11K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	422	$11K
86038		<1%	1,493	$11K
85049		<1%	3,202	$11K
99214	Doctor's office visit, returning patient (more involved)	<1%	275	$11K
70547		<1%	1,492	$11K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	230	$11K
C1729	Catheter, drainage	<1%	2,532	$10K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,205	$10K
83615		<1%	4,634	$10K
93798		<1%	310	$10K
J1815	Injection, insulin, per 5 units	<1%	23,349	$10K
83020		<1%	1,277	$10K
86835		<1%	298	$10K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	756	$10K
19083		<1%	13	$10K
70481		<1%	45	$9K
77001		<1%	1,279	$9K
92522		<1%	71	$9K
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	501	$9K
16020		<1%	600	$9K
82550		<1%	14,348	$9K
77470		<1%	36	$9K
77387		<1%	1,558	$9K
96411		<1%	1,323	$8K
97750		<1%	469	$8K
78582		<1%	172	$8K
96450		<1%	145	$8K
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	451	$8K
81001		<1%	21,868	$8K
31624		<1%	78	$8K
88312		<1%	7,821	$8K
99215	Doctor's office visit, returning patient (complex)	<1%	267	$8K
86834		<1%	298	$8K
87631		<1%	244	$8K
87075		<1%	2,863	$8K
95951		<1%	608	$7K
88342		<1%	3,103	$7K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	357	$7K
81025		<1%	16,202	$7K
87081		<1%	7,876	$7K
64450		<1%	159	$7K
73000		<1%	621	$7K
92567		<1%	1,246	$7K
J9045	Injection, carboplatin, 50 mg	<1%	884	$7K
62328		<1%	42	$7K
76857		<1%	3,894	$7K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	126	$7K
87015		<1%	3,038	$7K
97022		<1%	639	$7K
92579		<1%	688	$7K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,066	$7K
86403		<1%	1,233	$7K
93325		<1%	1,612	$7K
78226		<1%	110	$7K
76882		<1%	248	$7K
88112		<1%	1,166	$7K
0450	Emergency room services	<1%	199	$6K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	471	$6K
85652		<1%	13,819	$6K
73523		<1%	1,055	$6K
84681		<1%	335	$6K
93880		<1%	728	$6K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,009	$6K
74181		<1%	196	$6K
82077		<1%	10,105	$6K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	2,326	$6K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,155	$6K
87102		<1%	1,265	$6K
72128		<1%	852	$6K
90715		<1%	6,402	$6K
93320		<1%	552	$6K
90686		<1%	2,344	$6K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,599	$6K
J2800	Injection, methocarbamol, up to 10 ml	<1%	3,564	$6K
29130		<1%	746	$6K
36590		<1%	51	$6K
99204	Doctor's office visit, new patient (more involved)	<1%	227	$6K
92557		<1%	403	$5K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	5,163	$5K
10061		<1%	74	$5K
87529		<1%	640	$5K
87116		<1%	1,318	$5K
82435		<1%	657	$5K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	281	$5K
82374		<1%	17	$5K
86334		<1%	721	$5K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	9,860	$5K
D1310		<1%	396	$5K
82108		<1%	111	$5K
72072		<1%	2,039	$5K
C1726	Catheter, balloon dilatation, non-vascular	<1%	46	$5K
P9037	Platelets, pheresis, leukocytes reduced, irradiated, each unit	<1%	53	$5K
88313		<1%	4,500	$5K
87206		<1%	1,306	$5K
80202		<1%	686	$5K
51702		<1%	1,553	$5K
43762		<1%	590	$5K
73620		<1%	495	$5K
84403		<1%	1,037	$4K
86480		<1%	515	$4K
95806		<1%	122	$4K
58558		<1%	30	$4K
74174		<1%	14	$4K
94760		<1%	3,676	$4K
80164		<1%	2,676	$4K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,544	$4K
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	15,064	$4K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	8,381	$4K
G1010	Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program	<1%	2,137	$4K
80185		<1%	960	$4K
73200		<1%	280	$4K
84153		<1%	1,601	$4K
59050		<1%	424	$4K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	15,781	$4K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	11,588	$4K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	7,303	$4K
74246		<1%	69	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	207	$3K
82378		<1%	1,965	$3K
86592		<1%	4,271	$3K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	5,651	$3K
95700		<1%	718	$3K
86300		<1%	1,287	$3K
72195		<1%	42	$3K
82140		<1%	3,186	$3K
83883		<1%	384	$3K
77338		<1%	66	$3K
43259		<1%	138	$3K
84479		<1%	81	$3K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,052	$3K
85045		<1%	3,937	$3K
78227		<1%	47	$3K
72192		<1%	78	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	1,768	$3K
25605		<1%	85	$3K
95819		<1%	72	$3K
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	226	$3K
86870		<1%	121	$3K
87522	Neg quan hep c or qual rna	<1%	140	$3K
94762		<1%	484	$3K
72157		<1%	99	$3K
J1940	Injection, furosemide, up to 20 mg	<1%	4,812	$3K
10080		<1%	39	$3K
C9113	Injection, pantoprazole sodium, per vial	<1%	15,269	$3K
51701		<1%	2,601	$3K
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	58	$3K
84146		<1%	386	$3K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	243	$3K
86803		<1%	1,990	$3K
85384		<1%	1,112	$3K
82785		<1%	482	$3K
31500		<1%	167	$2K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	47	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	326	$2K
56420		<1%	28	$2K
G0238	Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)	<1%	251	$2K
85347		<1%	615	$2K
82670		<1%	260	$2K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	18	$2K
70250		<1%	192	$2K
82553		<1%	328	$2K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	492	$2K
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	1,319	$2K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,014	$2K
83630		<1%	247	$2K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	50	$2K
84550		<1%	5,878	$2K
83525		<1%	1,107	$2K
82105		<1%	613	$2K
84157		<1%	1,387	$2K
62270		<1%	93	$2K
A0429	Emergency ambulance ride, basic life support	<1%	14	$2K
86003		<1%	499	$2K
D1206	Topical application of fluoride varnish	<1%	162	$2K
88184		<1%	1,982	$2K
84466		<1%	1,706	$2K
J0456	Injection, azithromycin, 500 mg	<1%	2,061	$2K
80195		<1%	291	$2K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	365	$2K
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	282	$2K
87807		<1%	170	$2K
86762		<1%	1,478	$2K
12013		<1%	215	$2K
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	1,787	$2K
90670		<1%	421	$2K
90732		<1%	52	$2K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,455	$2K
82945		<1%	1,143	$2K
72170		<1%	818	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,868	$2K
82570		<1%	7,873	$2K
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	3,187	$2K
82627		<1%	97	$2K
D1120	Dental cleaning, child	<1%	392	$2K
86665		<1%	487	$2K
D1330		<1%	327	$1K
73600		<1%	306	$1K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	44	$1K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	166	$1K
94729		<1%	308	$1K
87449		<1%	1,449	$1K
74019		<1%	245	$1K
82024		<1%	224	$1K
J9250	Methotrexate sodium, 5 mg	<1%	384	$1K
G0008	Administration of influenza virus vaccine	<1%	321	$1K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	68	$1K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	469	$1K
82232		<1%	165	$1K
87324		<1%	1,359	$1K
92611		<1%	565	$1K
82248		<1%	2,941	$1K
87505		<1%	304	$1K
97010		<1%	547	$1K
94726		<1%	207	$1K
OP250		<1%	250	$1K
82365		<1%	171	$1K
J0207	Injection, amifostine, 500 mg	<1%	42	$997.04
73120		<1%	142	$994.61
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	980	$979.73
80179		<1%	6,828	$947.30
86880		<1%	15	$938.87
86787		<1%	639	$935.57
43760		<1%	16	$923.49
87184		<1%	1,852	$907.26
77012		<1%	821	$903.96
S0028	Injection, famotidine, 20 mg	<1%	1,283	$878.29
72084		<1%	34	$875.08
87536		<1%	46	$854.46
88360		<1%	534	$848.97
97533		<1%	1,031	$835.08
70490		<1%	21	$821.95
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	14	$820.49
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,132	$801.83
J9070	Cyclophosphamide, 100 mg	<1%	71	$800.55
J1630	Injection, haloperidol, up to 5 mg	<1%	2,101	$796.88
87252		<1%	121	$787.96
83002		<1%	650	$786.20
87634		<1%	789	$769.31
P9046	Infusion, albumin (human), 25%, 20 ml	<1%	84	$750.26
84134		<1%	580	$719.43
36593		<1%	31	$691.81
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,288	$688.63
88311		<1%	937	$687.72
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,126	$677.66
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	17	$672.91
80162		<1%	116	$672.73
J0640	Injection, leucovorin calcium, per 50 mg	<1%	871	$642.73
76942		<1%	250	$633.31
G0148	Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening	<1%	236	$616.67
70480		<1%	37	$597.89
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	397	$570.69
83001		<1%	763	$566.69
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	428	$557.78
G0379	Direct admission of patient for hospital observation care	<1%	448	$556.66
87181		<1%	397	$549.78
82150		<1%	2,153	$547.69
87147		<1%	2,930	$540.50
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	13	$537.61
72080		<1%	18	$533.35
J9190	Injection, fluorouracil, 500 mg	<1%	776	$522.71
80156		<1%	251	$506.76
87046		<1%	456	$490.46
83521		<1%	79	$487.72
83516		<1%	937	$474.17
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	2,089	$462.85
90714		<1%	192	$462.68
86376		<1%	697	$458.66
L1906	Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf	<1%	15	$448.30
85460		<1%	29	$439.01
94150		<1%	244	$437.25
80184		<1%	117	$395.03
72146		<1%	52	$390.46
82043		<1%	2,325	$388.69
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	65	$388.22
82575		<1%	15	$364.03
87641		<1%	145	$361.30
76981		<1%	13	$358.60
80178		<1%	30	$352.84
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	61	$344.30
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	246	$341.82
A9567	Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries	<1%	121	$341.39
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	173	$336.69
87045		<1%	294	$336.58
95713		<1%	27	$332.40
10120		<1%	18	$322.28
93321		<1%	695	$317.13
77062		<1%	922	$316.42
86800		<1%	246	$309.44
86352		<1%	89	$303.76
J3411	Injection, thiamine hcl, 100 mg	<1%	1,145	$297.87
82397		<1%	125	$266.41
49465		<1%	102	$263.68
J0290	Injection, ampicillin sodium, 500 mg	<1%	31	$259.43
86364		<1%	431	$258.27
11730		<1%	13	$256.33
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	89	$216.47
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	147	$214.55
88142		<1%	75	$205.65
86645		<1%	341	$201.39
84480		<1%	869	$199.54
0042T		<1%	18	$192.82
87640		<1%	119	$188.95
82950		<1%	140	$184.25
85007		<1%	2,386	$178.69
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	9,987	$178.04
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	569	$173.54
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	27	$165.79
85060		<1%	72	$159.21
82977		<1%	1,222	$155.85
86769		<1%	226	$153.28
86301		<1%	80	$153.17
72220		<1%	31	$139.80
J9370	Vincristine sulfate, 1 mg	<1%	1,031	$139.00
V2632	Posterior chamber intraocular lens	<1%	189	$138.66
97129		<1%	145	$136.30
J1790	Injection, droperidol, up to 5 mg	<1%	3,316	$132.83
86644		<1%	419	$129.69
88302		<1%	542	$114.16
77003		<1%	40	$110.68
94200		<1%	50	$108.14
86430		<1%	448	$102.00
85246		<1%	16	$96.92
87899		<1%	608	$96.47
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	119	$94.38
84305		<1%	311	$85.74
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	329	$84.58
86039		<1%	145	$81.06
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	36	$79.38
86255		<1%	185	$74.58
70160		<1%	18	$73.49
86225		<1%	73	$69.77
86308		<1%	989	$66.65
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	34	$62.77
86704		<1%	122	$62.66
76802		<1%	23	$59.00
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	316	$49.83
82652		<1%	26	$49.81
83520		<1%	17	$46.73
97035		<1%	31	$46.17
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	33	$45.50
86160		<1%	66	$41.82
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,256	$40.51
87185		<1%	68	$37.02
82270		<1%	61	$36.67
A9585	Injection, gadobutrol, 0.1 ml	<1%	142	$30.38
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	615	$30.27
86141		<1%	126	$25.96
86147		<1%	20	$24.59
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	12	$24.46
82747		<1%	12	$24.23
86695		<1%	112	$23.72
94664		<1%	12	$20.61
89051		<1%	87	$19.88
72070		<1%	208	$19.84
85660		<1%	122	$18.70
84478		<1%	48	$16.27
84402		<1%	15	$15.89
99406		<1%	13	$15.67
80175		<1%	17	$15.16
82272		<1%	113	$14.43
83655		<1%	33	$10.67
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	317	$8.74
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	169	$8.71
88108		<1%	329	$8.50
86735		<1%	16	$6.72
86765		<1%	16	$6.72
83930		<1%	37	$4.72
94644		<1%	177	$4.44
85362		<1%	95	$1.26
51798		<1%	53	$0.89
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	0%	146	$0.00
D0272	Bitewings - two radiographic images	0%	35	$0.00
C1768	Graft, vascular	0%	45	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	291	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	300	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	99	$0.00
Q3014	Telehealth originating site facility fee	0%	145	$0.00
0001A		0%	12	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	14	$0.00
76377		0%	81	$0.00
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	0%	56	$0.00
J2791	Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu	0%	69	$0.00
88738		0%	13	$0.00
D3240		0%	32	$0.00
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	0%	24	$0.00
99205	Prolong outpt/office vis	0%	12	$0.00
D0230	Intraoral - periapical each additional radiographic image	0%	26	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	52	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	75	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	14	$0.00
86258		0%	118	$0.00
83498		0%	30	$0.00
84300		0%	17	$0.00
82626		0%	13	$0.00
84270		0%	27	$0.00
76820		0%	16	$0.00
74420		0%	17	$0.00
86664		0%	15	$0.00
87071		0%	36	$0.00
90723		0%	40	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	73	$0.00
31720		0%	115	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	42	$0.00
D0220	Intraoral - periapical first radiographic image	0%	47	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	1,208	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	31	$0.00
J9206	Injection, irinotecan, 20 mg	0%	25	$0.00
86663		0%	16	$0.00
J0834	Injection, cosyntropin, 0.25 mg	0%	29	$0.00
93356		0%	139	$0.00
85245		0%	16	$0.00
87329		0%	42	$0.00
87328		0%	41	$0.00
90648		0%	75	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	33	$0.00
83003		0%	28	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	51	$0.00
87336		0%	38	$0.00
D0350		0%	15	$0.00
D2940		0%	40	$0.00
15853		0%	22	$0.00
76376		0%	16	$0.00
90675		0%	27	$0.00
82042		0%	34	$0.00
86235		0%	25	$0.00
J9000	Injection, doxorubicin hydrochloride, 10 mg	0%	48	$0.00
86705		0%	14	$0.00
87149		0%	20	$0.00
62323		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOHNSON, KENT (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under JOHNSON, KENT

Full network →

Provider	Location	Paid
Polk County Social Services	Crookston, MN	$3.55M
Estrella Internal Medicine and Pediatrics PC	Goodyear, AZ	$90K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.